Tag Archives: HRTX

Best China Stocks To Watch For 2019

It’s no secret that General Motors (NYSE:GM) has been thriving in China in recent years, and more recently driving a wider sales gap between its crosstown rival, Ford Motor Company (NYSE:F), in the region. However, the company seemed to hit a speed bump when sales during the second quarter posted a meager 0.7% increase compared to the prior year. Fortunately, its 8% gain during the first quarter helped salvage a 4.4% gain during the first half of 2018 — but what held GM back during the second quarter, and will it rebound?

The breakdown

The biggest surprise in GM’s second-quarter China data was easily Buick, with a 16.2% year-over-year decline to 230,454 units. Not only was that a significant drop, but Buick was the only brand out of five under GM’s umbrella in China to post a decline. Buick is a cornerstone of the automaker’s success in China. It was GM’s best-selling brand in the region last year, and it helped drive GM’s 2017 China sales to top 4 million for the first time. Wuling, GM’s best-selling brand in the region through the first six months of 2018 (thanks to Buick’s speed bump), also had a slow second quarter, with a modest 3.1% gain to 248,297 units, and it remains 5.5% lower year to date.

Best China Stocks To Watch For 2019: Long Island Iced Tea Corp. (LTEA)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

  • [By ]

    5. Blockchain-Related Stocks
    Shorting blockchain-related stocks is an ideal way to not only short bitcoin but also short the entire cryptocurrency craze. Many such stocks exist, such as Riot Blockchain (Nasdaq: RIOT), Long Blockchain (Nasdaq: LTEA), and Longfin (Nasdaq: LFIN). Choose the one that you think is most overhyped and short away!

  • [By ]

    Long Island Ice Tea changed its name to Long Blockchain (Nasdaq: LTEA), sending shares 200% higher. It remains to be seen how a beverage maker will create shareholder value from blockchain technology — not that its investors care. 

Best China Stocks To Watch For 2019: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys of Apple Inc. (NASDAQ:AAPL) and USG Corporation (NYSE:USG), and a recent Baker Brothers buy of Heron Therapeutics Inc (NASDAQ:HRTX). 

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Logan Wallace]

    Headlines about Heron Therapeutics (NASDAQ:HRTX) have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Heron Therapeutics earned a media sentiment score of 0.23 on Accern’s scale. Accern also gave media headlines about the biotechnology company an impact score of 48.1976713050328 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Joseph Griffin]

    Rhumbline Advisers grew its stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 20.7% in the second quarter, Holdings Channel reports. The fund owned 59,401 shares of the biotechnology company’s stock after acquiring an additional 10,173 shares during the period. Rhumbline Advisers’ holdings in Heron Therapeutics were worth $2,308,000 at the end of the most recent quarter.

Best China Stocks To Watch For 2019: Wynn Resorts, Limited(WYNN)

Advisors’ Opinion:

  • [By Travis Hoium]

    The gaming industry may not be the first place you would look for dividend stocks, but it has some surprisingly strong dividends right now. Las Vegas Sands (NYSE:LVS), Wynn Resorts (NASDAQ:WYNN), and Melco Resorts (NASDAQ:MLCO) all have strong cash flows and solid dividend yields for investors. 

  • [By Max Byerly]

    Morgan Stanley reissued their hold rating on shares of Wynn Resorts (NASDAQ:WYNN) in a research report sent to investors on Thursday morning.

    Several other analysts have also issued reports on WYNN. Zacks Investment Research lowered shares of Wynn Resorts from a buy rating to a hold rating in a research report on Wednesday, March 7th. Jefferies Financial Group reiterated a buy rating and issued a $200.00 target price on shares of Wynn Resorts in a research report on Thursday, March 8th. Susquehanna Bancshares lifted their target price on shares of Wynn Resorts from $211.00 to $214.00 and gave the company a positive rating in a research report on Thursday, March 8th. BidaskClub upgraded shares of Wynn Resorts from a hold rating to a buy rating in a research report on Friday, March 9th. Finally, Vetr lowered shares of Wynn Resorts from a strong-buy rating to a buy rating and set a $211.61 target price on the stock. in a research report on Monday, March 12th. Ten investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock currently has an average rating of Buy and a consensus target price of $202.65.

  • [By Logan Wallace]

    Rhumbline Advisers lifted its holdings in shares of Wynn Resorts, Limited (NASDAQ:WYNN) by 20.2% in the second quarter, HoldingsChannel reports. The firm owned 181,221 shares of the casino operator’s stock after acquiring an additional 30,407 shares during the period. Rhumbline Advisers’ holdings in Wynn Resorts were worth $30,326,000 at the end of the most recent reporting period.

  • [By Money Morning Staff Reports]

    Wynn Resorts Ltd. (NASDAQ: WYNN), the famous Las Vegas casino operation, popped 913% since 2002.

    And the maker of Corona beer and Svedka Vodka, Constellation Brands Inc. (NYSE: STZ), puts the others to shame with an eye-popping 30,638% gain since 1989. That doesn’t even include the dividends you’d have racked up along the way.

  • [By Travis Hoium]

    Shares of gaming giant Wynn Resorts, Limited (NASDAQ:WYNN) dropped 14.6% in June, according to data provided by S&P Global Market Intelligence, as gaming trends in Macau turned against the company.

  • [By Travis Hoium]

    Despite all of the challenges Wynn Resorts, Limited (NASDAQ:WYNN) has faced in the past year, the company continues to perform well in all of its markets. It’s gaining share in the competitive Macau market and is expanding an already profitable business in Las Vegas. Within a year, it’ll also add Encore Boston Harbor, its first foray to the East Coast. 

Best Warren Buffett Stocks To Watch For 2019

We generally don’t know what stocks Warren Buffett and the rest of Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) stock-picking team are buying until the company’s 13-F is released. However, Buffett confirmed in a recent interview that he has bought two stocks in particular since the second quarter ended.

Specifically, Berkshire’s Apple (NASDAQ:AAPL) stake has gotten even larger, and the company has started buying back its own stock for the first time in years. Here’s a rundown of what we know, why Buffett could be making these moves, and whether investors should follow Buffett’s lead and invest in these two companies.

Image Source: Getty Images.

Even more Apple

Tech giant and iPhone maker Apple is already the largest stock position in Berkshire Hathaway’s portfolio by a wide margin. As of the end of the second quarter, Berkshire owned nearly 252 million shares of Apple, which translates to more than 5% of the trillion-dollar company and is worth about $56.7 billion at the current share price.

Best Warren Buffett Stocks To Watch For 2019: MutualFirst Financial Inc.(MFSF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media coverage about MutualFirst Financial (NASDAQ:MFSF) has trended somewhat negative recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MutualFirst Financial earned a news impact score of -0.01 on Accern’s scale. Accern also assigned news articles about the bank an impact score of 47.9474560000459 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MutualFirst Financial (MFSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on MutualFirst Financial (MFSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    MutualFirst Financial, Inc. (NASDAQ:MFSF) – Stock analysts at DA Davidson increased their Q3 2018 earnings per share (EPS) estimates for shares of MutualFirst Financial in a research report issued to clients and investors on Monday, July 30th. DA Davidson analyst K. Reevey now forecasts that the bank will earn $0.68 per share for the quarter, up from their previous forecast of $0.62. DA Davidson has a “Neutral” rating on the stock. DA Davidson also issued estimates for MutualFirst Financial’s Q4 2018 earnings at $0.69 EPS, FY2018 earnings at $2.55 EPS and FY2019 earnings at $2.79 EPS.

Best Warren Buffett Stocks To Watch For 2019: Corbus Pharmaceuticals Holdings, Inc.(CRBP)

Advisors’ Opinion:

  • [By Keith Speights]

    Three of the biggest winners this week were Viking Therapeutics (NASDAQ:VKTX), Acadia Pharmaceuticals (NASDAQ:ACAD), and Corbus Pharmaceuticals (NASDAQ:CRBP). What drove these biotech stocks higher — and are they buys now? 

  • [By Keith Speights]

    Biotech

    GW Pharmaceuticals (NASDAQ:GWPH) $3.7 billion
      Cara Therapeutics (NASDAQ: CARA) $697 million
      Insys Therapeutics (NASDAQ: INSY) $473 million
      22nd Century Group (NYSEMKT: XXII) $313 million
      Corbus Pharmaceuticals (NASDAQ: CRBP) $271 million

    Ancillary provider

  • [By Sean Williams]

    Among drug developers, none had a more disappointing quarter than small-cap, clinical-stage company Corbus Pharmaceuticals (NASDAQ:CRBP), which fell more than 17%. Corbus is associated with the marijuana industry through its lead drug lenabasum (formerly anabasum), which is an oral endocannabinoid-mimetic drug that binds with naturally occurring CB2 receptors expressed on fibroblasts and immune cells. In particular, lenabasum is being targeted at four indications: systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

Best Warren Buffett Stocks To Watch For 2019: RadiSys Corporation(RSYS)

Advisors’ Opinion:

  • [By Logan Wallace]

    RadiSys (NASDAQ: RSYS) and Fortinet (NASDAQ:FTNT) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends.

  • [By Joseph Griffin]

    RadiSys (NASDAQ: RSYS) and Stratasys (NASDAQ:SSYS) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on RadiSys (RSYS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Warren Buffett Stocks To Watch For 2019: Innoviva, Inc. (INVA)

Advisors’ Opinion:

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we asked three Motley Fool investors to name one healthcare stock that’s tops on their list for the month of June. These three mid-cap stocks made the cut: royalty drug company Innoviva (NASDAQ:INVA), mental illness treatment center operator Acadia Healthcare (NASDAQ:ACHC), and health savings account provider HealthEquity (NASDAQ:HQY).

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Innoviva (INVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Virginia Retirement Systems ET AL lifted its holdings in shares of Innoviva Inc (NASDAQ:INVA) by 67.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 145,100 shares of the biotechnology company’s stock after acquiring an additional 58,700 shares during the period. Virginia Retirement Systems ET AL’s holdings in Innoviva were worth $2,002,000 at the end of the most recent reporting period.

Best Warren Buffett Stocks To Watch For 2019: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys of Apple Inc. (NASDAQ:AAPL) and USG Corporation (NYSE:USG), and a recent Baker Brothers buy of Heron Therapeutics Inc (NASDAQ:HRTX). 

  • [By Max Byerly]

    Heron Therapeutics Inc (NASDAQ:HRTX) – Equities researchers at Cantor Fitzgerald issued their FY2019 earnings per share (EPS) estimates for shares of Heron Therapeutics in a report issued on Thursday, July 19th. Cantor Fitzgerald analyst L. Chen anticipates that the biotechnology company will post earnings of ($0.23) per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $50.00 price objective on the stock.

  • [By Joseph Griffin]

    Shares of Heron Therapeutics Inc (NASDAQ:HRTX) dropped 0.2% on Thursday . The stock traded as low as $29.30 and last traded at $30.95. Approximately 33,849 shares traded hands during trading, a decline of 96% from the average daily volume of 944,129 shares. The stock had previously closed at $31.00.

  • [By George Budwell]

    Shares of the commercial-stage biotech Heron Therapeutics (NASDAQ:HRTX) gained as much as 36.3% today on abnormally high volume. What triggered this massive surge higher? 

  • [By George Budwell]

    As things stand now, Cara’s immediate future hinges directly on the strength of Korsuva’s late-stage results in both postoperative pain and CKD-associated pruritus. Having said that, I think investors should largely consider the drug’s postoperative pain indication as icing on the cake at this point. Heron Therapeutics’ (NASDAQ:HRTX)experimental pain medicine HTX-011, after all, appears to have a sizable advantage in terms of efficacy over Korsuva based on the trial data so far. And Heron is almost certainly going to beat Cara to market by several years as well, giving it a formidable first-mover advantage. 

Top Clean Energy Stocks To Own Right Now

Mention the word uranium and most likely weapons of mass destruction come to mind. While you can make plenty of jokes about investment returns in the event of nuclear war, choosing to diversify your portfolio with uranium mining stocks is certainly worth a closer look.

Azincourt Uranium Inc. (OTCBB: AZURF) (TSX: AAZ.V) the Canadian based resource company specializing in the strategic acquisition, exploration and development of uranium properties, recently announced that it has completed the acquisition of an option to gain an undivided 70-percent stake in a mining project in the Athabasca Basin of Saskatchewan. This allows the mining company to increase exploration and production mining in a region known to be rich in base minerals.

The significance of this is twofold: as climate change continues to be a global issue, the demand for clean energy is rising. And as demand rises, so too does the number of nuclear reactors under construction worldwide. In China alone there were 20 nuclear reactors under construction at the end of March, 2017.

Top Clean Energy Stocks To Own Right Now: Integrated Electrical Services Inc.(IESC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Gendell Jeffrey L decreased its stake in shares of IES Holdings Inc (NASDAQ:IESC) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,319,064 shares of the technology company’s stock after selling 36,081 shares during the period. IES comprises 21.0% of Gendell Jeffrey L’s portfolio, making the stock its largest holding. Gendell Jeffrey L owned about 0.58% of IES worth $186,634,000 as of its most recent filing with the Securities & Exchange Commission.

Top Clean Energy Stocks To Own Right Now: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By George Budwell]

    As things stand now, Cara’s immediate future hinges directly on the strength of Korsuva’s late-stage results in both postoperative pain and CKD-associated pruritus. Having said that, I think investors should largely consider the drug’s postoperative pain indication as icing on the cake at this point. Heron Therapeutics’ (NASDAQ:HRTX)experimental pain medicine HTX-011, after all, appears to have a sizable advantage in terms of efficacy over Korsuva based on the trial data so far. And Heron is almost certainly going to beat Cara to market by several years as well, giving it a formidable first-mover advantage.

  • [By Chris Lange]

    Heron Therapeutics Inc. (NASDAQ: HRTX) shares saw a massive gain on Thursday after the company announced a few key developments. First, the firm provided positive results from its midstage trial, as well as a critical update from the U.S. Food and Drug Administration (FDA).

  • [By George Budwell]

    Shares of the commercial-stage biotech Heron Therapeutics (NASDAQ:HRTX) gained as much as 36.3% today on abnormally high volume. What triggered this massive surge higher?

  • [By Dan Caplinger]

    Thursday was a poor day on Wall Street, with major benchmarks giving up about 0.5%-1% across the board. Trade concerns remain the focal point for market participants, with the latest controversy over U.S. immigration policy posing a potential threat to relations with traditional American allies abroad as well. Even with worries on a big-picture level, some individual companies had good news that sent their shares higher. Stitch Fix (NASDAQ:SFIX), Barnes & Noble Education (NYSE:BNED), and Heron Therapeutics (NASDAQ:HRTX) were among the best performers on the day. Here’s why they did so well.

Top Clean Energy Stocks To Own Right Now: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of the clinical-stage biotech Ziopharm Oncology (NASDAQ:ZIOP) rose by a healthy 16% last month,according toS&P Global Market Intelligence. What sparked this sizable rally?

  • [By Keith Speights]

    If you like putting money into the beaten-down stocks of clinical-stage biotechs, Ziopharm Oncology (NASDAQ:ZIOP) and Celldex Therapeutics (NASDAQ:CLDX) might warrant a look. Ziopharm’s share price has dropped more than 25% so far in 2018, while Celldex stock has plunged more than 80%.

  • [By Todd Campbell]

    It garnered a lot of attention in 2015 when Ziopharm (NASDAQ:ZIOP) announced it would use its “sleeping beauty” technology to improve upon chimeric antigen receptor T-cell therapies that it was developing. Then, its mosquitoes that are engineered so that they can’t reproduce and spread disease won investor interest during the Zika virus outbreak in 2015 and 2016.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) fell 42 percent to $2.25 in pre-market trading after dropping 31.45 percent on Thursday. Stellar Biotechnologies priced 2.075 million units at price of $2.65 per unit.
    Symantec Corporation (NASDAQ: SYMC) shares fell 25.2 percent to $21.82 in pre-market trading. Symantec reported better-than-expected earnings for its fourth quarter, but issued weak second-quarter guidance.
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares fell 9.5 percent to $10 in pre-market trading after surging 7.79 percent on Thursday.
    ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) fell 8.9 percent to $4.11 in pre-market trading after the company posted wider-than-expected Q1 loss.
    Redfin Corporation (NASDAQ: RDFN) fell 8.6 percent to $21.00 in pre-market trading after reporting Q1 results.
    Geron Corporation (NASDAQ: GERN) fell 8.3 percent to $3.33 in pre-market trading. Geron posted a Q1 loss of $0.04 per share.
    Talend S.A. (NASDAQ: TLND) shares fell 6 percent to $56 in pre-market trading after reporting Q1 results.
    Flotek Industries, Inc. (NYSE: FTK) fell 5.4 percent to $3.54 in pre-market trading after dropping 2.35 percent on Thursday.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 5.1 percent to $18.95 in pre-market trading after reporting Q1 results.
    Yelp Inc. (NYSE: YELP) shares fell 4.9 percent to $45.40 in pre-market trading. Yelp reported stronger-than-expected results for its first quarter on Thursday.
    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares fell 3.3 percent to $7.50 in pre-market trading after dropping 4.32 percent on Thursday

Top Clean Energy Stocks To Own Right Now: SEACOR Holdings, Inc.(CKH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Headlines about Seacor (NYSE:CKH) have been trending somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Seacor earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned media headlines about the oil and gas company an impact score of 45.3315874804175 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Stephan Byrd]

    State of Tennessee Treasury Department reduced its stake in shares of Seacor Holdings, Inc. (NYSE:CKH) by 9.5% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 11,943 shares of the oil and gas company’s stock after selling 1,254 shares during the period. State of Tennessee Treasury Department owned approximately 0.07% of Seacor worth $610,000 at the end of the most recent quarter.

Top 10 Performing Stocks To Watch For 2019

Source: ThinkstockJanuary 30, 2018: The S&P 500 closed down 1.1% at 2,822.49. The DJIA closed down 1.4% at 26,077.71. Separately, the Nasdaq down 0.9% at 7,402.48.

Tuesday was a down day for the U.S. markets, and in fact the worst day that weve seen in a long time. This is also the second consecutive day for the markets pulling back and the biggest 2-day point loss in the Dow since Brexit inJune 2016. Crude oil continued to fall as the week went on, down below $65. The S&P 500 sectors were almost all negative in Mondays session. The most positive sector was utilities up 0.3%. The worst performing sectors were health care, energy, and financials down 1.9%, 1.8%, and 1.0%, respectively.

Crude oil was down 1.8% at $64.38.

Top 10 Performing Stocks To Watch For 2019: Stewart Information Services Corporation(STC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    StarChain (CURRENCY:STC) traded 8.7% lower against the US dollar during the 24-hour period ending at 20:00 PM E.T. on May 14th. StarChain has a market cap of $0.00 and approximately $5.27 million worth of StarChain was traded on exchanges in the last 24 hours. One StarChain token can now be purchased for about $0.0925 or 0.00001062 BTC on major cryptocurrency exchanges. During the last seven days, StarChain has traded down 16.3% against the US dollar.

  • [By Stephan Byrd]

    Argo Group (NASDAQ: AGII) and Stewart Information Services (NYSE:STC) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

  • [By Max Byerly]

    Sangoma Technologies (CVE:STC) has been assigned a C$2.00 price objective by investment analysts at Acumen Capital in a research report issued to clients and investors on Tuesday. The brokerage currently has a “buy” rating on the stock. Acumen Capital’s target price suggests a potential upside of 70.94% from the stock’s current price.

  • [By Logan Wallace]

    StarChain (CURRENCY:STC) traded 13% higher against the U.S. dollar during the one day period ending at 22:00 PM E.T. on June 3rd. StarChain has a total market capitalization of $0.00 and approximately $3.20 million worth of StarChain was traded on exchanges in the last day. One StarChain token can currently be purchased for about $0.0814 or 0.00001057 BTC on major cryptocurrency exchanges. In the last seven days, StarChain has traded 1.2% lower against the U.S. dollar.

  • [By Stephan Byrd]

    StarChain (CURRENCY:STC) traded down 2.8% against the dollar during the one day period ending at 21:00 PM Eastern on May 31st. One StarChain token can now be bought for about $0.0729 or 0.00000971 BTC on exchanges. StarChain has a market cap of $0.00 and approximately $2.12 million worth of StarChain was traded on exchanges in the last day. In the last seven days, StarChain has traded down 18.5% against the dollar.

Top 10 Performing Stocks To Watch For 2019: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Forward Pharma A/S (NASDAQ: FWP) fell 15.2 percent to $3.51 in pre-market trading after surging 88.18 percent on Tuesday.
    Pfenex Inc. (NASDAQ: PFNX) shares fell 15 percent to $5.85 in pre-market trading after the company announced an offering of common stock.
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) fell 17.6 percent to $47.75 in pre-market trading after the company reported downbeat results for its first quarter and issued a weak earnings forecast for the second quarter.
    Container Store Group, Inc. (NYSE: TCS) fell 13 percent to $7.15 in pre-market trading after reporting weaker-than-expected earnings for its fourth quarter.
    Ardelyx, Inc. (NASDAQ: ARDX) shares fell 12.1 percent to $4.00 in pre-market trading after reporting pricing of public offering of common stock.
    Boston Scientific Corporation (NYSE: BSX) shares fell 9.8 percent to $27.31 in pre-market trading.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) fell 6.5 percent to $6.60 in pre-market trading.
    Target Corporation (NYSE: TGT) shares fell 5.8 percent to $71.02 in pre-market trading. Target reported weaker-than-expected earnings for its first quarter, while sales exceeded estimates.
    PBF Energy Inc. (NYSE: PBF) shares fell 5.7 percent to $42.42 in pre-market trading

  • [By Lisa Levin] Gainers
    Forward Pharma A/S (NASDAQ: FWP) shares gained 88.18 percent to close at $4.14 on Tuesday.
    Regional Health Properties, Inc. (NYSE: RHE) shares jumped 18.04 percent to close at $0.3010 on Tuesday.
    Precipio, Inc. (NASDAQ: PRPO) shares gained 16.61 percent to close at $0.49 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.
    Arcturus Therapeutics Ltd. (NASDAQ: ARCT) rose 16.09 percent to close at $7.00 on Tuesday.
    America's Car-Mart, Inc. (NASDAQ: CRMT) gained 14.53 percent to close at $62.65 after reporting upbeat Q4 results.
    NanoString Technologies, Inc. (NASDAQ: NSTG) shares surged 12.64 percent to close at $13.19.
    Geron Corporation (NASDAQ: GERN) gained 12.12 percent to close at $4.07 on Tuesday.
    Quotient Limited (NASDAQ: QTNT) shares climbed 11.58 percent to close at $6.55 on Tuesday.
    American Equity Investment Life Holding Company (NYSE: AEL) rose 11.23 percent to close at $32.28 following a report from Reuters that the company is looking for a sale.
    iQIYI, Inc. (NASDAQ: IQ) gained 11.15 percent to close at $22.52.
    Veracyte, Inc. (NASDAQ: VCYT) rose 10.4 percent to close at $7.11.
    Stein Mart, Inc. (NASDAQ: SMRT) gained 10.26 percent to close at $3.33. Stein Mart is expected to release quarterly earnings on May 23.
    MiMedx Group, Inc. (NASDAQ: MDXG) shares rose 10.11 percent to close at $8.06.
    The Container Store Group, Inc. (NYSE: TCS) gained 8.2 percent to close at $8.18. Container Store reported weaker-than-expected earnings for its fourth quarter after the closing bell.
    Photronics, Inc. (NASDAQ: PLAB) shares gained 7.69 percent to close at $9.10 after the company reported upbeat Q2 results.
    Micron Technology, Inc. (NASDAQ: MU) rose 6.4 percent to close at $59.03 after reporting a $10 billion buyback plan.

     

Top 10 Performing Stocks To Watch For 2019: Columbia Sportswear Company(COLM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Brasada Capital Management LP grew its stake in shares of Columbia Sportswear (NASDAQ:COLM) by 25.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,669 shares of the textile maker’s stock after purchasing an additional 1,148 shares during the quarter. Brasada Capital Management LP’s holdings in Columbia Sportswear were worth $433,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Columbia Sportswear (NASDAQ:COLM) hit a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $88.86 and last traded at $88.27, with a volume of 4020 shares traded. The stock had previously closed at $87.29.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Columbia Sportswear (COLM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch For 2019: Fibrocell Science Inc(FCSC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Fibrocell alerts:

    Year-to-date (YTD) in the Spotlight Fibrocell Science, Inc. (NASDAQ:FCSC), eMagin Corporation (NYSE:EMAN … (stocksnewspoint.com) Have an eye on: Fibrocell Science, Inc. (NASDAQ:FCSC), Kelso Technologies Inc. (NYSE:KIQ), Siebert Financial Corp … (journalfinance.net) Fibrocell Science (FCSC) Sees Hammer Chart Pattern: Time to Buy? (finance.yahoo.com) Chester County gene therapy company completes $6M stock sale (finance.yahoo.com) Wining Three Stocks: MasTec, Inc. (NYSE:MTZ), Fibrocell Science, Inc. (NASDAQ:FCSC), Volt Information Sciences … (thestreetpoint.com)

    Shares of FCSC traded down $0.16 during mid-day trading on Friday, hitting $2.40. 283,121 shares of the company’s stock were exchanged, compared to its average volume of 206,910. The stock has a market capitalization of $14.57 million, a PE ratio of -0.29 and a beta of 0.45. Fibrocell has a fifty-two week low of $2.21 and a fifty-two week high of $23.20.

  • [By Lisa Levin]

    Fibrocell Science, Inc. (NASDAQ: FCSC) was down, falling around 13 percent to $2.51. Fibrocell reported a $6.0 million registered direct offering priced at-the-market

  • [By Alexander Bird]

    We’re talking 471% potential gains…

    Penny Stock Current Share Price Last Week’s Gain
    Renren Inc. (NYSE: RENN) $2.50 158.64%
    Astrotech Corp. (Nasdaq: ASTC) $4.17 132.80%
    Xenetic Biosciences Inc. (Nasdaq: XBIO) $5.58 71.95%
    Nordic American Tanker Shipping Ltd. (NYSE: NAT) $2.73 38.43%
    United States Antimony Corp. (NYSE: UAMY) $0.49 36.47%
    Soeno Therapeutics Inc. (Nasdaq: SLNO) $2.65 33.05%
    Fibrocell Science Inc. (Nasdaq: FCSC) $3.16 31.36%
    Teekay Tankers Ltd. (NYSE: TNK) $1.30 29.70%
    Neovasc Inc. (Nasdaq: NVCN) $0.04 27.30%
    Actinium Pharmaceuticals Inc. (OTCMKTS: ATNM) $0.24 25.98%

    While the gains of last week’s top penny stocks are exciting, investors who know where to look can unlock even bigger gains…

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Fibrocell Science (FCSC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Shares of Fibrocell Science, Inc. (NASDAQ: FCSC) were down 10 percent to $2.58. Fibrocell reported a $6.0 million registered direct offering priced at-the-market.

Top 10 Performing Stocks To Watch For 2019: RealD Inc(RLD)

Advisors’ Opinion:

  • [By Shane Hupp]

    News coverage about RealD (NYSE:RLD) has been trending somewhat negative on Thursday, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. RealD earned a news impact score of -0.11 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.1473505020268 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 10 Performing Stocks To Watch For 2019: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Chris Lange]

    Heron Therapeutics Inc. (NASDAQ: HRTX) shares saw a massive gain on Thursday after the company announced a few key developments. First, the firm provided positive results from its midstage trial, as well as a critical update from the U.S. Food and Drug Administration (FDA).

  • [By George Budwell]

    Shares of the commercial-stage biotech Heron Therapeutics (NASDAQ:HRTX) gained as much as 36.3% today on abnormally high volume. What triggered this massive surge higher?

Top 10 Performing Stocks To Watch For 2019: Franklin Covey Company(FC)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Franklin Covey (NYSE:FC) Q3 2018 Earnings Conference CallJun. 27, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By WWW.GURUFOCUS.COM]

    For the details of Osmium Partners, LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Osmium+Partners%2C+LLC

    These are the top 5 holdings of Osmium Partners, LLCRosetta Stone Inc (RST) – 1,912,104 shares, 16.55% of the total portfolio. Shares reduced by 3.7%Tucows Inc (TCX) – 333,179 shares, 12.28% of the total portfolio. Shares added by 0.62%Franklin Covey Co (FC) – 618,000 shares, 10.94% of the total portfolio. Franklin Covey Co (FC) – 580,490 shares, 10.28% of the total portfolio. Shares added by 9.77%Leaf Group Ltd (LF

Top 10 Performing Stocks To Watch For 2019: CryoLife, Inc.(CRY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    CryoLife (NYSE:CRY) issued an update on its FY18 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.29-0.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.31. The company issued revenue guidance of $250-256 million, compared to the consensus revenue estimate of $252.86 million.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on CryoLife (CRY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch For 2019: Lannett Co Inc(LCI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    McDermott International, Inc. (NYSE: MDR) rose 19 percent to $7.20 in pre-market trading. Subsea 7 S.A. confirmed a $7.00 per share proposal to acquire McDermott.
    Clarus Corporation (NASDAQ: CLAR) rose 18.5 percent to $8.00 in pre-market trading.
    Enbridge Inc. (NYSE: ENB) rose 9.3 percent to $34.09 in pre-market trading after falling 2.41 percent on Friday.
    Lannett Company, Inc. (NYSE: LCI) rose 8.4 percent to $18 in pre-market trading. Lannett named Maureen M. Cavanaugh as senior vice president and chief commercial operations officer.
    Navios Maritime Midstream Partners L.P. (NYSE: NAP) rose 7.1 percent to $4.55 in pre-market trading after gaining 11.26 percent on Friday.
    Corcept Therapeutics Incorporated (NASDAQ: CORT) rose 6.9 percent to $18.80 in pre-market trading after falling 3.19 percent on Friday.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 5.7 percent to $2.40 in pre-market trading after falling 10.98 percent on Friday.
    Vectren Corporation (NYSE: VVC) shares rose 5.6 percent to $69.20 in pre-market trading. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash
    Genprex, Inc. (NASDAQ: GNPX) shares rose 5.2 percent to $4.50 in pre-market trading.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 5.1 percent to $3.70 in pre-market trading after declining 19.35 percent on Friday.
    Sangamo Therapeutics, Inc. (NASDAQ: SGMO) shares rose 5 percent to $20 in pre-market trading.
    Magellan Midstream Partners, L.P. (NYSE: MMP) shares rose 5 percent to $68.41 in pre-market trading.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares rose 4.9 percent to $19.78 in the pre-market trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By ]

    It’s how, over the past three years, my subscribers and I have seen gains like 181% on Lannett (NYSE: LCI), 135% on Westmoreland Coal (Nasdaq: WLB), and 242% from Bitauto (NYSE: BITA). Each time, the system has told us exactly when to buy and when to sell, while we just sit back and count the returns.

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Amazon.com Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By ]

    With luck, we’ll one day be able to add these stocks to our long list of home runs. Over the past three years, my subscribers and I have seen gains like 181% on Lannett (NYSE: LCI), 135% on Westmoreland Coal (Nasdaq: WLB), and a striking 242% on Bitauto (NYSE: BITA). Each time, the Maximum Profit system has told us exactly when to buy and when to sell, while we just sit back and count the returns.

Top 10 Performing Stocks To Watch For 2019: Iteris, Inc.(ITI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Iteris (NASDAQ: ITI) and UTStarcom (NASDAQ:UTSI) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.

  • [By Shane Hupp]

    Iteris (NASDAQ: ITI) and Napco Security Technologies (NASDAQ:NSSC) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Iteris (ITI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    iTicoin (CURRENCY:ITI) traded 21.2% higher against the U.S. dollar during the one day period ending at 20:00 PM Eastern on June 2nd. iTicoin has a total market capitalization of $543,370.00 and approximately $61.00 worth of iTicoin was traded on exchanges in the last 24 hours. In the last week, iTicoin has traded up 20.2% against the U.S. dollar. One iTicoin coin can currently be bought for approximately $16.98 or 0.00222465 BTC on major exchanges including BTC Trade UA, BTC-Alpha, Cryptopia and Livecoin.

Hot Blue Chip Stocks To Invest In Right Now

Coca-Cola Co. (NYSE: KO) is scheduled to release its first-quarter earnings report before the markets open on Tuesday. The consensus forecast calls for $0.46 in earnings per share (EPS) on $7.31 billion in revenue. The same period of last year reportedly had $0.43 in EPS on $9.13 billion in revenue.

This company has paid dividends for more years than most investors can count, and the beverage giants dividend hike to $0.39 from $0.37 per quarter in February 2018 marked the 56th consecutive annual dividend increase. At the current share price, Coca-Colas stock has unfortunately been stuck in a long-term trading range with limited gains.

Coca-Cola had been considered down and out and dead money for so long that no one seemed to ever want to give its shares much recognition. It is far from a major growth stock in most investors minds, but its defensive stock characteristics make it a core holding for many blue chip investors.

After Coca-Colas most recent positive earnings report, it looks like the stock is finally starting to command more respect from Wall Street analysts. And Warren Buffett also has maintained his strong stake in Coca-Cola after all these years. Coca-Cola was a disappointment in performance in the sell-off after considering it was named among 15 defensive stocks that should survive just fine over time.

Hot Blue Chip Stocks To Invest In Right Now: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Chris Lange]

    Heron Therapeutics Inc. (NASDAQ: HRTX) shares saw a massive gain on Thursday after the company announced a few key developments. First, the firm provided positive results from its midstage trial, as well as a critical update from the U.S. Food and Drug Administration (FDA).

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Dan Caplinger]

    Thursday was a poor day on Wall Street, with major benchmarks giving up about 0.5%-1% across the board. Trade concerns remain the focal point for market participants, with the latest controversy over U.S. immigration policy posing a potential threat to relations with traditional American allies abroad as well. Even with worries on a big-picture level, some individual companies had good news that sent their shares higher. Stitch Fix (NASDAQ:SFIX), Barnes & Noble Education (NYSE:BNED), and Heron Therapeutics (NASDAQ:HRTX) were among the best performers on the day. Here’s why they did so well.

Hot Blue Chip Stocks To Invest In Right Now: VivoPower International PLC (VVPR)

Advisors’ Opinion:

  • [By Ross Cameron – Warrior Trading]

    This is why I have a quicker sell trigger when I trade names like LM Funding America (NASDAQ: LMFA), which lept from $0.60 to just under a dollar earlier this week, or even VivoPower International PLC (NASDAQ: VVPR), which I traded for a $200 loss on Monday when it spiked up 225 percent.

  • [By Money Morning News Team]

    Just look at VivoPower International Plc. (Nasdaq: VVPR), the penny stock that topped our list of the 10 top penny stocks to watch this week.

  • [By Lisa Levin] Gainers
    athenahealth, Inc. (NASDAQ: ATHN) shares climbed 23.2 percent to $155.19 after Elliott Management confirmed a $160 per share cash offer for athenahealth.
    Evolus, Inc. (NASDAQ: EOLS) gained 21.3 percent to $8.83. Evolus named David Moatazedi as new CEO.
    VivoPower International PLC (NASDAQ: VVPR) climbed 18.2 percent to $3.12 after falling 39.86 percent on Friday.
    Gramercy Property Trust (NYSE: GPT) rose 15.6 percent to $27.53 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    EP Energy Corporation (NYSE: EPE) rose 13 percent to $2.26.
    Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) gained 11.9 percent to $7.35.
    National CineMedia, Inc. (NASDAQ: NCMI) surged 11.8 percent to $6.24 after the company posted upbeat quarterly profit.
    Sanchez Energy Corporation (NYSE: SN) shares gained 11.3 percent to $3.56.
    CVR Refining, LP (NYSE: CVRR) shares rose 8.8 percent to $18.875.
    Monaker Group, Inc. (NASDAQ: MKGI) rose 8.7 percent to $2.9683.
    Kosmos Energy Ltd. (NYSE: KOS) shares rose 7.4 percent to $7.40.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 7 percent to $2.88 after climbing 1.89 percent on Friday.
    Cloudera, Inc. (NYSE: CLDR) surged 6 percent to $15.93. Craig-Hallum initiated coverage on Cloudera with a Buy rating.
    Illumina, Inc. (NASDAQ: ILMN) rose 5.1 percent to $257.35. Barclays upgraded Illumina from Equal-Weight to Overweight.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Lisa Levin] Gainers
    Bioblast Pharma Ltd. (NASDAQ: ORPN) shares rose 29.6 percent to $3.22.
    Mannatech, Incorporated (NASDAQ: MTEX) surged 23.3 percent to $19.60 after the company reported commencement of modified Dutch auction cash tender for up to $16 million of common stock.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.1 percent to $15.8003.
    Quotient Limited (NASDAQ: QTNT) gained 18.1 percent to $5.54 following commencement of EU blood grouping field trial.
    Shineco, Inc. (NASDAQ: TYHT) climbed 17.1 percent to $1.9899 following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    CPI Card Group Inc. (NASDAQ: PMTS) rose 17 percent to $3.0999.
    Dover Downs Gaming & Entertainment, Inc. (NYSE: DDE) shares climbed 12 percent to $2.2613. The stock spiked more than 14 percent Thursday near the close as traders circulate word the Delaware lottery is planning to introduce full sports betting in June.
    Harte Hanks, Inc. (NYSE: HHS) shares gained 7.2 percent to $11.05 after the company late Thursday appointed four new independent directors to board.
    Cronos Group Inc. (NASDAQ: CRON) rose 6.4 percent to $6.17.
    VivoPower International PLC (NASDAQ: VVPR) shares gained 6.3 percent to $3.74.
    Global Self Storage, Inc. (NASDAQ: SELF) shares climbed 6 percent to $4.20.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

Hot Blue Chip Stocks To Invest In Right Now: MBIA, Inc.(MBI)

Advisors’ Opinion:

  • [By Shane Hupp]

    MBIA Inc. (NYSE:MBI) saw unusually large options trading on Tuesday. Stock investors purchased 13,349 call options on the company. This represents an increase of 1,714% compared to the average daily volume of 736 call options.

  • [By Dan Caplinger]

    The stock market finished lower on Friday, with triple-digit losses for the Dow Jones Industrial Average and modest declines of as much as half a percent for other major benchmarks. A mix of economic and political news kept investors on their toes to end the week, as fears of a possible attack on Syria watered down some of the potential upside that could have stemmed from solid earnings results from the banking sector during the morning. Even though many investors have pretty positive expectations going into earnings season, some companies suffered from disappointing news that sent their shares lower. Arista Networks (NYSE:ANET), Dropbox (NASDAQ:DBX), and MBIA (NYSE:MBI) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Logan Wallace]

    Monster Byte (CURRENCY:MBI) traded up 32.2% against the dollar during the 1-day period ending at 8:00 AM E.T. on June 8th. Monster Byte has a market cap of $851,113.00 and $940.00 worth of Monster Byte was traded on exchanges in the last 24 hours. One Monster Byte token can now be purchased for about $0.0506 or 0.00000668 BTC on cryptocurrency exchanges. In the last week, Monster Byte has traded flat against the dollar.

Hot Blue Chip Stocks To Invest In Right Now: Fogo de Chao, Inc.(FOGO)

Advisors’ Opinion:

  • [By Dustin Parrett]

    But with a VQScore of 4, our top score, this company is one of the best stocks you can buy right now, which means the Raymond James rating might be too conservative. Not only are you getting a company with growth potential, you’re getting it at an excellent price.

    Restaurant Stocks to Buy, No. 2: Fogo de Chao Inc. (Nasdaq: FOGO)

    Fogo de Chao Inc. (Nasdaq: FOGO) is upscale Brazilian steakhouse, originally opened in Brazil in 1979. Fogo de Chao currently has 47 restaurants across the world.

  • [By Max Byerly]

    Fogo De Chao (NASDAQ: FOGO) and Habit Restaurants (NASDAQ:HABT) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Hot Blue Chip Stocks To Invest In Right Now: The Bon-Ton Stores, Inc.(BONT)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Not long ago, liquidation seemed inevitable for bankrupt department store operator Bon-Ton Stores Inc. (NASDAQ:BONT). The company’s desperate attempt to restructure outside the bankruptcy process failed earlier this year when it couldn’t find an investor willing to finance a comeback effort.

  • [By Adam Levine-Weinberg]

    Last week, bankrupt department store operator Bon-Ton Stores (NASDAQ:BONT) made one last desperate bid to survive. A group led by mall owners Namdar Realty Group and Washington Prime Group (NYSE:WPG) signed a letter of intent to buy the company out of bankruptcy and continue operating at least some of its stores.

  • [By Adam Levine-Weinberg]

    However, the outlook for J.C. Penney stock could be improving as competition in the department store sector starts to wane. Sears Holdings (NASDAQ:SHLD) recently revealed another round of store closures. Furthermore, Bon-Ton (NASDAQ:BONT) announced this week that it will liquidate after its attempt to emerge from bankruptcy as a going concern failed.

  • [By Adam Levine-Weinberg]

    In 2018, TJX will benefit from a lower tax rate and easier year-over-year comparisons. It is also likely to be one of the biggest beneficiaries of Bon-Ton Stores’ (NASDAQ:BONT) pending liquidation. This could send TJX stock to new heights later this year.

Top 10 Heal Care Stocks To Buy For 2018

There are currently 13,373 publicly-traded securities on U.S. exchanges. Of those, there are 2,100 stocks currently paying a dividend.

Now, any knucklehead with a computer can generate a list of the market’s highest-yielding stocks in five minutes, but that’s no way to find a good investment. Investing is not as simple as buying anything with a double-digit yield.

—Sponsored Link—

Ignore All Doubters.The Perfect Investment Does Exist
Every investor faces the same dilemma — Shoot for huge returns. and you put way too much capital at risk. Choose safety and your cash is spread so thin you barely break even. Our brand new primer “The Right Investment at the Perfect Time” reveals a simple way to stay in one single investment. while enjoying ALL the benefits of full diversification! CLICK HERE to put this little-known technique to work for you.

I’ve warned readers before about blindly buying these super-aggressive yielders. Nine times out of 10, a stock yielding more than 15% is likely in big trouble.

Top 10 Heal Care Stocks To Buy For 2018: Pinnacle West Capital Corporation(PNW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Atria Investments LLC cut its stake in shares of Pinnacle West Capital Co. (NYSE:PNW) by 49.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,651 shares of the utilities provider’s stock after selling 4,560 shares during the period. Atria Investments LLC’s holdings in Pinnacle West Capital were worth $371,000 as of its most recent filing with the SEC.

  • [By Logan Wallace]

    Bank of America upgraded shares of Pinnacle West Capital (NYSE:PNW) from an underperform rating to a neutral rating in a research note issued to investors on Friday morning, Marketbeat.com reports. Bank of America currently has $81.00 target price on the utilities provider’s stock. The analysts noted that the move was a valuation call.

  • [By Joseph Griffin]

    M&T Bank Corp raised its position in Pinnacle West Capital Co. (NYSE:PNW) by 15.8% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 8,775 shares of the utilities provider’s stock after purchasing an additional 1,196 shares during the period. M&T Bank Corp’s holdings in Pinnacle West Capital were worth $700,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    ING Groep NV lifted its holdings in shares of Pinnacle West Capital Co. (NYSE:PNW) by 7.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,423 shares of the utilities provider’s stock after acquiring an additional 800 shares during the quarter. ING Groep NV’s holdings in Pinnacle West Capital were worth $912,000 at the end of the most recent quarter.

  • [By Jon C. Ogg]

    Pinnacle West Capital Corp. (NYSE: PNW) was raised to Outperform from Neutral and the price target was raised to $87 from $85 at Credit Suisse.

    Salesforce.com Inc. (NYSE: CRM) was reiterated as Outperform and the price target was raised to $140 from $125 at JMP Securities.

Top 10 Heal Care Stocks To Buy For 2018: Cognizant Technology Solutions Corporation(CTSH)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Amazon.com Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is projected to report quarterly earnings at $1.32 per share on revenue of $9.89 billion.
    Sysco Corporation (NYSE: SYY) is estimated to report quarterly earnings at $0.64 per share on revenue of $14.34 billion.
    Louisiana-Pacific Corporation (NYSE: LPX) is expected to report quarterly earnings at $0.67 per share on revenue of $692.63 million.
    Cognizant Technology Solutions Corporation (NASDAQ: CTSH) is estimated to report quarterly earnings at $1.06 per share on revenue of 3.90 billion.
    Manchester United plc (NYSE: MANU) is estimated to report quarterly loss at $1.35 per share on revenue of $193.67 million.
    Sempra Energy (NYSE: SRE) is expected to report quarterly earnings at $1.66 per share on revenue of $3.24 billion.
    Willis Towers Watson Public Limited Company (NYSE: WLTW) is projected to report quarterly earnings at $3.01 per share on revenue of $2.23 billion.
    Green Plains Inc. (NASDAQ: GPRE) is estimated to report quarterly loss at $0.28 per share on revenue of $922.42 million.
    TravelCenters of America LLC (NASDAQ: TA) is projected to report quarterly loss at $0.16 per share on revenue of $1.59 billion.
    Gannett Co., Inc. (NYSE: GCI) is expected to report quarterly earnings at $0.03 per share on revenue of $723.93 million.
    Welbilt, Inc. (NYSE: WBT) is estimated to report quarterly earnings at $0.11 per share on revenue of $329.71 million.
    Horizon Pharma Public Limited Company (NASDAQ: HZNP) is projected to report quarterly earnings at $0.07 per share on revenue of $234.17 million.

     

  • [By Joseph Griffin]

    State Board of Administration of Florida Retirement System lowered its holdings in shares of Cognizant (NASDAQ:CTSH) by 1.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 837,118 shares of the information technology service provider’s stock after selling 11,877 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Cognizant were worth $67,388,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Paradigm Asset Management Co. LLC reduced its stake in Cognizant (NASDAQ:CTSH) by 6.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 31,900 shares of the information technology service provider’s stock after selling 2,100 shares during the period. Paradigm Asset Management Co. LLC’s holdings in Cognizant were worth $2,568,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Heal Care Stocks To Buy For 2018: Werner Enterprises, Inc.(WERN)

Advisors’ Opinion:

  • [By Max Byerly]

    Werner Enterprises (NASDAQ: WERN) and Universal Logistics (NASDAQ:ULH) are both transportation companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

  • [By ]

    Werner Enterprises (Nasdaq: WERN) competes in the full-truckload (FTL) segment of the industry where drivers deliver entire truck-loads between two points, rather than making many stops to consolidate partial loads as in the LTL segment. This could mean that the company has relatively more to gain from autonomous trucking since highway driving is a larger portion of total drive time.

Top 10 Heal Care Stocks To Buy For 2018: Karyopharm Therapeutics Inc.(KPTI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Karyopharm Therapeutics (NASDAQ:KPTI) – Investment analysts at Jefferies Group lowered their Q2 2018 earnings estimates for Karyopharm Therapeutics in a research note issued on Tuesday, May 15th. Jefferies Group analyst M. Raycroft now forecasts that the company will post earnings per share of ($0.77) for the quarter, down from their prior estimate of ($0.62). Jefferies Group has a “Buy” rating on the stock. Jefferies Group also issued estimates for Karyopharm Therapeutics’ Q3 2018 earnings at ($0.71) EPS, Q4 2018 earnings at ($0.78) EPS, FY2018 earnings at ($3.03) EPS, FY2019 earnings at ($2.66) EPS, FY2020 earnings at ($1.05) EPS, FY2021 earnings at ($0.74) EPS and FY2022 earnings at $0.73 EPS.

  • [By Stephan Byrd]

    Karyopharm Therapeutics (NASDAQ:KPTI) last issued its quarterly earnings data on Thursday, March 15th. The company reported ($0.80) EPS for the quarter, missing the consensus estimate of ($0.66) by ($0.14). The business had revenue of $1.53 million during the quarter, compared to the consensus estimate of $2.26 million. During the same quarter in the prior year, the firm posted ($0.65) earnings per share. The company’s revenue for the quarter was up 3163.8% compared to the same quarter last year. analysts anticipate that Karyopharm Therapeutics will post -2.82 earnings per share for the current fiscal year.

  • [By Shane Hupp]

    Karyopharm Therapeutics Inc (NASDAQ:KPTI) – Wedbush issued their Q1 2019 earnings estimates for Karyopharm Therapeutics in a research note issued on Thursday, May 24th. Wedbush analyst D. Nierengarten expects that the company will earn ($0.75) per share for the quarter. Wedbush has a “Neutral” rating and a $19.00 price target on the stock. Wedbush also issued estimates for Karyopharm Therapeutics’ Q2 2019 earnings at ($0.75) EPS, Q3 2019 earnings at ($0.71) EPS and Q4 2019 earnings at ($0.67) EPS.

  • [By Benzinga News Desk]

    Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link

    ECONOMIC DATA
    US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M
    Existing home sales report for April will be released at 10:00 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET.
    Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET.
    The Treasury is set to auction 7-year notes at 1:00 p.m. ET.
    The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET.
    Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET.
    Data on money supply for the latest week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    UBS upgrades Deere (NYSE: DE) from Neutral to Buy
    Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform
    Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold
    Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Top 10 Heal Care Stocks To Buy For 2018: Flanigan’s Enterprises Inc.(BDL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 10 Heal Care Stocks To Buy For 2018: Zogenix, Inc.(ZGNX)

Advisors’ Opinion:

  • [By Sean Williams]

    The other concern is that while it may be the first to market in treating Dravet syndrome and Lennox-Gastaut syndrome, another experimental therapy is nipping at its heels. In September, Zogenix (NASDAQ:ZGNX) announced surprisingly strong phase 3 data for ZX008, a low-dose fenfluramine that absolutely blew away the placebo in Dravet syndrome patient testing. Zogenix’s lead compound led to a 72.4% reduction in convulsive seizure frequency over a 14-week period, compared to the 17.4% reduction for placebo patients.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Zogenix (ZGNX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams]

    Back in September, drug developer Zogenix (NASDAQ:ZGNX) announced data from ZX008 in late-stage trials that absolutely wowed Wall Street. ZX008, which is a low-dose fenfluramine, led to a 72.4% reduction in seizure frequency from baseline over a 14-week testing period. This compared very favorably with a 17.4% reduction in seizure frequency from baseline observed with the placebo.

  • [By Sean Williams]

    But what’s interesting about Epidiolex is that its first-to-market advantage may not hold up for too long. You see, Zogenix (NASDAQ:ZGNX)also is developing a treatment for Dravet syndrome, known as ZX008, that it plans to test on LGS patients soon. In phase 3 Dravet syndrome trials, Zogenix’s lead drug wound up demonstrating a 72.4% reduction in convulsive seizure frequency over the 14-week treatment period relative to baseline. This more than quadrupled the 17.4% reduction in convulsive seizure frequency seen in placebo patients.

  • [By Logan Wallace]

    DekaBank Deutsche Girozentrale bought a new stake in Zogenix (NASDAQ:ZGNX) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 14,700 shares of the company’s stock, valued at approximately $575,000.

Top 10 Heal Care Stocks To Buy For 2018: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 Heal Care Stocks To Buy For 2018: Potash Corporation of Saskatchewan Inc.(POT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Headlines about Potash Co. of Saskatchewan (NYSE:POT) (TSE:POT) have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Potash Co. of Saskatchewan earned a news impact score of 0.43 on Accern’s scale. Accern also gave media coverage about the fertilizer maker an impact score of 45.4285202328488 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    PotCoin (CURRENCY:POT) traded 0.6% higher against the US dollar during the 24 hour period ending at 23:00 PM E.T. on May 12th. PotCoin has a total market capitalization of $23.95 million and approximately $62,522.00 worth of PotCoin was traded on exchanges in the last 24 hours. During the last seven days, PotCoin has traded 17.8% lower against the US dollar. One PotCoin coin can now be purchased for approximately $0.11 or 0.00001293 BTC on popular cryptocurrency exchanges including Cryptopia, CoinExchange, Trade By Trade and Tux Exchange.

Top 10 Heal Care Stocks To Buy For 2018: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 10 Heal Care Stocks To Buy For 2018: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By Trey Thoelcke]

    Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is poised to post its most recent quarterly results before regular trading begins on Thursday. The consensus forecast is $0.66 in EPS and $4.80 billion in revenue. Shares closed at $17.83 apiece. The consensus price target is $19.33, and the 52-week range is $10.850 to $33.82.

  • [By ]

    Teva Pharmaceutical Industries Ltd.  (TEVA) isn’t out of the weeds just yet.

    Teva’s shares finished in the red, despite a strong earnings beat and further measures to reduce its $30 billion-plus debt pile. Though things appear to be turning Teva shares closed down 4.4% to $17.78.

  • [By Trey Thoelcke]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Eli Lilly & Co. (NYSE: LLY) are among companies developing similar treatments.

    Stewart J. Tepper, MD, Professor of Neurology at the Geisel School of Medicine at Dartmouth Medical School, said:

  • [By Cory Renauer]

    Warren Buffett’s famous for telling investors to be greedy when others are fearful, but buying Teva Pharmaceuticals Industries(NYSE:TEVA) last year seemed like searching for loose change in a burning building. Generic drug prices began collapsing just after the company borrowed heavily to become the world’s largest generic drug producer, and that was just one disaster of many that forced the company to slash its dividend last year.

  • [By Garrett Baldwin]

    Yesterday, the Fed Open Market Committee announced it would not raise interest rates this session. The central bank committee, which is in charge of monetary policy, said that inflation is rising and that the U.S. economy is getting better. Markets are now looking forward to the next meeting on June 12 for the U.S. Federal Reserve to bump rates higher for the second time in 2018. Shares of Tesla Inc. (Nasdaq: TSLA) slumped more than 4.5% after Tesla CEO Elon Musk held an highly unusual earnings call. After announcing that his firm burned through $700 million in cash during the quarter of 2018, Musk refused to take any more questions on the company’s fiscal health, dismissing analysts’ questions as “boring.” Musk instead spent the rest of the quarterly call taking questions from a YouTuber named Gali Russell who had lobbied Musk on Twitter to let him partake in the earnings call. This morning, the U.S. Labor Department reported initial jobless claims rose by 2,000, to 211,000. Analysts had projected 225,000 for the week. The tightening U.S. labor market has now seen the total number of Americans receiving benefits fall to the lowest level since 1973. America’s unemployment rate is sitting at 4.1%, the lowest figure in 17 years. Tomorrow, the Labor Department will release the April jobs report.
    Four Stocks to Watch Today: GPRO, SPOT, CI
    GoPro Inc. (Nasdaq: GPRO) will lead another busy day of earnings reports on Wall Street. The firm will report earnings after the bell Thursday. Wall Street expects that the tech firm is about to report a loss of -$0.40 per share on top of $175.40 billion in revenue. Here’s a way to make a lot of money in a short time during earnings season. Spotify Technology SA(NYSE: SPOT) did not have a very good first earnings report. Shares plunged more than 8% after the firm’s music-streaming forecasts fell well short of expectations. During its earnings report, signals indicated that the firm’s growth could slow despite news that its

Top 10 Clean Energy Stocks To Buy Right Now

What happened

Shares ofClean Energy Fuels Corp.(NASDAQ:CLNE) surged as much as 22.7% today, before losing a little steam in afternoon trading. As of 12:20 p.m. EDT, shares were up 13.6% in very heavy trading. At this writing, more than 5 million shares have traded hands, about five times the average volume for the company’s stock.

Today’s big jump isn’t from the company’s earnings, which will be released later today after market close, but due to a surprise announcement that global oil and gas giantTotal S.A. (ADR)(NYSE:TOT) has agreed to take a 25% stake in Clean Energy, with a deal to buy 50.8 million shares for $83.4 million.

Image source: Clean Energy Fuels.

So what

In addition to an investment that would make Total the largest shareholder of Clean Energy stock, it is also partnering with the company to launch a leasing program to help accelerate adoption of heavy-duty natural gas vehicles. As part of this program, Total would provide up to $100 million of credit to fund leases.

Top 10 Clean Energy Stocks To Buy Right Now: Guidewire Software, Inc.(GWRE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    TRADEMARK VIOLATION NOTICE: “Insider Selling: Guidewire Software (GWRE) Insider Sells 209 Shares of Stock” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/3365485/insider-selling-guidewire-software-gwre-insider-sells-209-shares-of-stock.html.

Top 10 Clean Energy Stocks To Buy Right Now: Simulations Plus, Inc.(SLP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Simulations Plus (NASDAQ:SLP) shares hit a new 52-week high and low during mid-day trading on Monday . The company traded as low as $18.55 and last traded at $18.35, with a volume of 49668 shares changing hands. The stock had previously closed at $18.20.

  • [By Ethan Ryder]

    Simulations Plus (NASDAQ:SLP) was upgraded by equities research analysts at ValuEngine from a “buy” rating to a “strong-buy” rating in a research report issued on Monday.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Simulations Plus (SLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Buy Right Now: Boeing Company (BA)

Advisors’ Opinion:

  • [By Paul Ausick]

    Last Wednesday The Boeing Co. (NYSE: BA) reported first-quarter 2018 results that pushed the share price up more than 4% for the day. On one hand, the company’s first quarter was as solid as management said it was. On the other hand, there were some significant omissions.

  • [By Todd Campbell, Leo Sun, and Daniel Miller]

    Long-term investing has been shown to be a much better way to building wealth than short-term trading, but figuring out what stocks are worth owning in portfolios for the long haul is challenging. If you’re struggling to decide what companies to buy, these three Motley Fool contributors can help. Here’s why they thinkIllumina, Inc. (NASDAQ:ILMN), The Boeing Company (NYSE:BA), and Square, Inc. (NYSE:SQ) could be perfect stocks to buy and hold for decades.

  • [By Paul Ausick]

    The Boeing Co. (NYSE: BA) traded up 2.39% at $335.28. The stock’s 52-week range is $175.47 to $371.60. Volume was about 20% below the daily average of around 6.4 million. The company had no specific news.

Top 10 Clean Energy Stocks To Buy Right Now: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 10 Clean Energy Stocks To Buy Right Now: Virtu Financial, Inc.(VIRT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P
  • [By Joseph Griffin]

    Virtu Financial (NASDAQ: VIRT) is one of 31 publicly-traded companies in the “Security brokers & dealers” industry, but how does it weigh in compared to its competitors? We will compare Virtu Financial to similar companies based on the strength of its earnings, risk, valuation, dividends, profitability, institutional ownership and analyst recommendations.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Extreme Networks, Inc. (NASDAQ: EXTR) fell 26 percent to $8.70 in pre-market trading after the company reported downbeat earnings for its third quarter and issued weak Q4 guidance.
    Caesarstone Ltd. (NASDAQ: CSTE) shares fell 12.5 percent to $16.15 in pre-market trading after the company reported downbeat Q1 results and lowered its FY18 sales forecast.
    MINDBODY, Inc. (NASDAQ: MB) fell 11.7 percent to $38.65 in pre-market trading following mixed Q1 results.
    Vivint Solar, Inc. (NYSE: VSLR) fell 10 percent to $3.60 in pre-market trading after reporting Q1 miss.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares fell 10 percent to $31.63 in pre-market trading after reporting a Q1 earnings miss at 28 cents per share, 5 cents below estimates.
    Monster Beverage Corporation (NASDAQ: MNST) fell 7.7 percent to $49.00 in pre-market trading after reporting downbeat quarterly earnings.
    MaxLinear, Inc. (NYSE: MXL) fell 6.1 percent to $22.39 in pre-market trading following Q1 earnings.
    Virtu Financial, Inc. (NASDAQ: VIRT) fell 5.3 percent to $31.1604 in pre-market trading after announcing a 15 million share common stock secondary offering.
    Papa John's International, Inc. (NASDAQ: PZZA) shares fell 4.7 percent to $56 in pre-market trading after reporting downbeat Q1 earnings

Top 10 Clean Energy Stocks To Buy Right Now: Encore Wire Corporation(WIRE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Encore Wire (NASDAQ: WIRE) and Arconic (NYSE:ARNC) are both industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Top 10 Clean Energy Stocks To Buy Right Now: Star Bulk Carriers Corp.(SBLK)

Advisors’ Opinion:

  • [By Rich Smith]

    Now those new buy recommendations are rolling in. This morning, Stifel Nicolaus — one of the best-rated analysts we have on Motley Fool CAPS — announced a pair of such upgrades, urging investors to buy stock in Scorpio Bulkers (NYSE:SALT) and Star Bulk Carriers (NASDAQ:SBLK). Here’s what you need to know.

Top 10 Clean Energy Stocks To Buy Right Now: Monmouth Real Estate Investment Corporation(MNR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Monmouth Real Estate Investment (MNR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Buy Right Now: Ternium S.A.(TX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Sumitomo (OTCMKTS: SSUMY) and Ternium (NYSE:TX) are both multi-sector conglomerates companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, risk, dividends and profitability.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By Logan Wallace]

    TT International cut its position in Ternium (NYSE:TX) by 24.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 865,613 shares of the basic materials company’s stock after selling 277,967 shares during the quarter. Ternium makes up about 1.2% of TT International’s holdings, making the stock its 10th biggest position. TT International owned about 0.43% of Ternium worth $28,123,000 at the end of the most recent reporting period.

Top 10 Clean Energy Stocks To Buy Right Now: ENSERVCO Corporation(ENSV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Enservco (NYSEAMERICAN:ENSV) will be issuing its quarterly earnings data before the market opens on Wednesday, May 9th.

    Enservco (NYSEAMERICAN:ENSV) last issued its earnings results on Thursday, March 22nd. The oil and gas producer reported ($0.04) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.03). Enservco had a negative return on equity of 89.94% and a negative net margin of 43.71%. The business had revenue of $14.13 million during the quarter.